EDGAR Filing Documents for 0001140361-17-044454

Form 8-K - Current report:

SEC Accession No. 0001140361-17-044454

Filing Date

2017-11-30

Accepted

2017-11-30 16:15:36

Documents

Period of Report

2017-11-28

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	form8k.htm	8-K	22537
2	EXHIBIT 10.1	ex10_1.htm	EX-10.1	45545
	Complete submission text file	0001140361-17-044454.txt		69355

Mailing Address 2855 GAZELLE CT CARLSBAD CA 92010

Business Address 55 CAMBRIDGE PARKWAY SUITE 100 CAMBRIDGE MA 02142 760-603-2732

AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)